Zobrazeno 1 - 10
of 431
pro vyhledávání: '"Wataru Ogawa"'
Autor:
Wataru Ogawa, Tatsuhiko Urakami, Takashi Kadowaki, Kalvin Kao, Laura Brandner, Kenichiro Shimizu, Timothy C. Dunn
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 10, Pp 1483-1488 (2024)
ABSTRACT Aims/Introduction The FreeStyle Libre (FSL) intermittently scanned continuous glucose monitoring (isCGM) system continually measures interstitial glucose levels and provides the data to users in numerical and graphical formats that guide use
Externí odkaz:
https://doaj.org/article/239baea89dda4345b5f509c4aef83f93
Autor:
Shin Urai, Hironori Bando, Mei Nakatsuji, Masaaki Yamamoto, Hidenori Fukuoka, Genzo Iguchi, Wataru Ogawa
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2024)
A 52-year-old female patient with breast cancer presented with a history of fatigue and malaise 1 year prior. She was diagnosed with isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) on endocrinological examination. Her pituitary gland sho
Externí odkaz:
https://doaj.org/article/522fabd562b8406c8a0cb39db5d77fd0
Autor:
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 9, Pp 1211-1219 (2024)
ABSTRACT Aims/Introduction Insulin resistance syndrome and lipoatrophic diabetes are rare conditions characterized by the development of treatment‐refractory diabetes with severe insulin resistance. We recently conducted a 24 week, multicenter, sin
Externí odkaz:
https://doaj.org/article/d60e2f3c3183423c9437d2a067c99250
Autor:
Michiko Takahashi, Takumi Imai, Tomoko Yamada, Naokazu Muramae, Kai Yoshimura, Yuji Mitomo, Hironori Bando, Kenji Sugawara, Shun-Ichiro Asahara, Yushi Hirota, Yoshikazu Tamori, Yutaka Takahashi, Wataru Ogawa
Publikováno v:
Clinical Nutrition Open Science, Vol 55, Iss , Pp 223-233 (2024)
Summary: Background & aim: Although weight loss programs including diet and exercise targeting patients with obesity are essential, the percentage of patients who successfully achieve weight loss is less than 10%. One cause of failure to achieve weig
Externí odkaz:
https://doaj.org/article/3b8c04be5b584693821fb7b7f1766850
Autor:
Kazuhiro Nomura, Shinichi Kinoshita, Nao Mizusaki, Yoko Senga, Tsutomu Sasaki, Tadahiro Kitamura, Hiroshi Sakaue, Aki Emi, Tetsuya Hosooka, Masahiro Matsuo, Hitoshi Okamura, Taku Amo, Alexander M. Wolf, Naomi Kamimura, Shigeo Ohta, Tomoo Itoh, Yoshitake Hayashi, Hiroshi Kiyonari, Anna Krook, Juleen R. Zierath, Masato Kasuga, Wataru Ogawa
Publikováno v:
Molecular Metabolism, Vol 86, Iss , Pp 101968- (2024)
The transcriptional coactivator PGC-1α has been implicated in the regulation of multiple metabolic processes. However, the previously reported metabolic phenotypes of mice deficient in PGC-1α have been inconsistent. PGC-1α exists as multiple isofo
Externí odkaz:
https://doaj.org/article/17003285f15f45a0a37f5fca4575d05c
Autor:
Wataru Ogawa, Palvi Gupta
Publikováno v:
Endocrine Journal, Vol 71, Iss 3, Pp 273-284 (2024)
Obesity is a focus of Japanese public health policy, due to Japanese individuals’ high susceptibility to weight-related conditions. In contrast to global definitions, obesity is defined as a body-mass-index (BMI) of ≥25 kg/m2 in Japan. Despite pu
Externí odkaz:
https://doaj.org/article/916743d7428a431080d29530a42413f9
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan
Autor:
Wataru Ogawa, Yushi Hirota, Shigeru Miyazaki, Tadashi Nakamura, Yoshihiro Ogawa, Iichiro Shimomura, Toshimasa Yamauchi, Koutaro Yokote, on behalf of the Creation Committee for Guidelines for the Management of Obesity Disease 2022 by Japan Society for the Study of Obesity (JASSO)
Publikováno v:
Endocrine Journal, Vol 71, Iss 3, Pp 223-231 (2023)
To identify those who might benefit from weight reduction within a large population of obese individuals, Japan Society for the Study of Obesity (JASSO) advocated the concept of “obesity disease.” Here we summarize the definition, criteria, and c
Externí odkaz:
https://doaj.org/article/bc07feec861241f3863052cdbc3c8874
Advantages of sensor‐augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus
Autor:
Hitomi Imafuku, Kenji Tanimura, Naohisa Masuko, Masako Tomimoto, Yutoku Shi, Akiko Uchida, Masashi Deguchi, Kazumichi Fujioka, Akane Yamamoto, Kei Yoshino, Yushi Hirota, Wataru Ogawa, Yoshito Terai
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 12, Pp 1383-1390 (2023)
Abstract Aims/Introduction To evaluate the efficacy of sensor‐augmented pump (SAP) for improving obstetric and neonatal outcomes among pregnant women with type 1 diabetes mellitus by comparing it with continuous subcutaneous insulin infusion plus s
Externí odkaz:
https://doaj.org/article/26ecd19cdcfb428bb893155b2baff059
Autor:
Yuriko Sasaki, Maki Kanzawa, Masaaki Yamamoto, Keitaro Kanie, Hironori Bando, Kei Yoshino, Yushi Hirota, Katsumi Shigemura, Masato Fujisawa, Wataru Ogawa, Hidenori Fukuoka
Publikováno v:
Endocrine Journal, Vol 71, Iss 1, Pp 65-74 (2023)
Pheochromocytomas and paragangliomas (PPGLs) are rare tumors that secrete catecholamines and arise from the adrenal medulla or extra-adrenal sympathetic ganglia. These tumors secrete adrenaline and noradrenaline, but paragangliomas usually produce on
Externí odkaz:
https://doaj.org/article/6ce2d70e071741ed810ffff72dc969b1
Autor:
Nanaho Kasahara, Yukiko Imi, Reina Amano, Masakazu Shinohara, Kumiko Okada, Yusei Hosokawa, Makoto Imamori, Chiaki Tomimoto, Jun Kunisawa, Shigenobu Kishino, Jun Ogawa, Wataru Ogawa, Tetsuya Hosooka
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The antidiabetic drug pioglitazone ameliorates insulin resistance by activating the transcription factor PPARγ. In addition to its blood glucose–lowering action, pioglitazone exerts pleiotropic effects including amelioration of nonalcohol
Externí odkaz:
https://doaj.org/article/2c4335dd8e044a929c350cef77d4879a